Eiger BioPharmaceuticals Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-03-31
|
-7.50
|
-49.39
|
-41.89
|
-558.53%
|
|
2023-12-31
|
-7.50
|
-49.39
|
-41.89
|
-558.53%
|
|
2023-09-30
|
-9.71
|
-12.30
|
-2.59
|
-26.67%
|
|
2023-06-30
|
-12.30
|
-14.10
|
-1.80
|
-14.63%
|
|
2023-03-31
|
-14.19
|
-15.60
|
-1.41
|
-9.94%
|
|
2022-12-31
|
0.00
|
-17.11
|
0.00
|
0.00%
|
|
2022-09-30
|
0.00
|
-18.48
|
0.00
|
0.00%
|
|
2022-06-30
|
0.00
|
-15.25
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-03-31
|
-49.39
|
|
2023-12-31
|
-91.39
|
|
2022-12-31
|
-70.11
|
|
2021-12-31
|
-30.15
|
|
2020-12-31
|
-69.68
|
|
2019-12-31
|
-92.94
|
|
2018-12-31
|
-113.55
|
|
2017-12-31
|
-144.19
|
|
2016-12-31
|
-1830.09
|